Clinical Trial Update: A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 study comparing GT267-004 to vancomycin and metronidazole for Clostridioides difficile infection with associated diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• GT267-004
• METRONIDAZOLE (Metronidazole)
• Vancomycin (vancomycin)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Clostridium Enterocolitis, Diarrhea | Phase 3 | Status: COMPLETED